(Q24244116)

1

0 references

Klaus Viktor Toyka

3

object named as

Klaus V Toyka

0 references

author name string

Philippe Gajdos

2

0 references

Reinhard R Hohlfeld

Cochrane Database of Systematic Reviews

4

0 references

publication date

20 April 2005

0 references

published in

0 references

cites work

Alternate-day prednisone: preliminary report of a double-blind controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

CORTICOTROPIN IN TREATMENT OF OCULAR MYASTHENIA; A CONTROLLED CLINICAL TRIAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

High-dose intravenous methylprednisolone in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Medical and surgical treatment for ocular myasthenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Mycophenolate mofetil for myasthenia gravis: an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Plasma exchange for myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Intravenous immunoglobulin for myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

The natural course of myasthenia gravis and effect of therapeutic measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Immunosuppressive agents for myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Acetylcholinesterase inhibitor treatment for myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Efficacy of low-dose FK506 in the treatment of Myasthenia gravis--a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Acute myopathy associated with large parenteral dose of corticosteroid in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Treatment of autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Mycophenolate mofetil in the therapy of severe myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Ocular myasthenia gravis: response to long-term immunosuppressive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

Ocular myasthenia: diagnostic and therapeutic problems

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

Effectiveness of steroid treatment in myasthenia gravis: a retrospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

Treatment of severe myasthenia gravis with large doses of ACTH

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

The use of ACTH and corticosteroids in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

A clinical therapeutic trial of cyclosporine in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

Long-term results of corticosteroid therapy in patients with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

Myasthenia gravis: prolonged treatment with steroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002828.PUB2

7 January 2021

10.1002/14651858.CD002828.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_sq4jvceybfdsxhoxhr3t5s5ugy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sq4jvceybfdsxhoxhr3t5s5ugy

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

15846640

1 reference

Consolidated OpenCitations Corpus – April 2017